Integrated DNA Technologies (IDT) has announced a global partnership with Hamilton, a company specializing in precision laboratory automation, to streamline next generation sequencing (NGS) workflows for researchers worldwide.
According to a release, the collaboration will combine IDT’s customizable sequencing tools with Hamilton’s automated liquid handling systems, allowing labs to more efficiently process genetic samples and accelerate discoveries in areas such as cancer research.
As part of the agreement, IDT’s xGen and Archer product lines will have automation scripts developed for use with Hamilton’s Microlab STAR and NIMBUS platforms. Together, the systems are designed to help scientists identify biomarkers – genetic indicators tied to diseases like solid tumors and blood cancers – with greater speed and accuracy.
“By pairing IDT’s flexible NGS solutions with Hamilton’s automation expertise, we’re removing constraints that may arise from one-size-fits-all approaches so labs can consistently and reliably accelerate their discoveries with confidence, precision and speed, at whatever scale their work demands,” said IDT President Ajay Gannerkote.
Michael Mouradian, Hamilton’s vice president of scientific strategy and market development, said the collaboration will help researchers improve efficiency. “We are enabling laboratories to achieve greater scalability, consistency and efficiency in their genomic discoveries,” he said.
For researchers, the automated system is expected to reduce time spent on manual lab work and free up resources for data analysis and discovery. The agreement also supports IDT’s broader mission to provide scalable, adaptable sequencing solutions that meet evolving research needs.
